According to the report Europe Anticoccidial Drugs Industry, published by Market Data Forecast, The Industry is estimated to grow from $699million in 2015 to $830 Million by 2020 at a CAGR of 3.5%.
Coccidiosis, a parasitic infection of the intestinal tract of animals is caused by coccidian protozoa. The disease feasts from one animal to another by any contact with infected faeces or consumption of infected tissue.
It infects a wide variety of animals, such as cattle, poultry, pigs and sheep which is effecting the volumes of meat production. To overcome this problem, anticoccidial drugs play an important role in the prevention and treatment of coccidiosis.
Browse Industry data tables and in-depth TOC of the Europe Anticoccidial Drugs Industry to 2020 @ www.marketdataforecast.com/market-…-drugs-market-23/
The ban on consumption of antibiotics as a source of animal feed and the upsurge in incidences of antibiotic microbes has seen a reduced growth in the antibiotic Industry, nevertheless the rising incidence of coccidiosis over the preceding 50 years and its control on the overall cost to benefit ratio for the meat industry has improved the anticoccidials drug Industry. In addition, the growing consumer preferences for healthy diet is increasing the demand for meat proteins.
This is further leading to the rise in usage of anticoccidial drugs by farmers, driving the European anticoccidial drugs Industry. The trend of owning companion animals is a causative to the mounting demand for anticoccidials in developed regions.
Free sample of the report is available @ www.marketdataforecast.com/market-…23/request-sample
The Europe anticoccidial drugs Industry is classified based on various types of animals and by type of drugs. The animal segment is sub-categorised into swine, fish, poultry, cattle and companion animals.
The companion animals segment is further analysed under dogs and cats. The livestock industry is currently enjoying the high growth rate owing to the increasing demand for meat in the European countries.
And on the basis of drug type the Industry is segmented into antibiotic anticoccidials, Ionophore anticoccidials and chemical derivative anticoccidials. Furthermore, on the basis of geography, the European Industry is analysed under various regions namely, UK, Spain, Italy, Germany and France.
The major players in the industry are facing various challenges related to microbial resistance build-up to therapeutics and government regulations in European Union. For this reason, many companies prefer to operate in less regulated Industrys.
Some of the key players operating in the Industry are Bayer Health care, Boehringer Ingelheim Animal Health, Elanco, Merial, Merck Animal Healthcare, Virbac, Zoetis, Ceva Santé Animale, Novartis Animal Healthcare and Smartvet Inc.
Enquire about report @ www.marketdataforecast.com/market-…market-23/inquire
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Europe Anticoccidial Drugs Industry: Segmentation
- By Drug Type
- o Antibiotic anticoccidials
- o Ionophore anticoccidials
- o Chemical derivative anticoccidials
- By Animal Type
- o Poultry
- o Swine
- o Fish
- o Cattle
- o Companion Animal
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Access report @ www.marketdataforecast.com/market-…/request-discount
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!